HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Goirand Selected Research

ethyl 4- (4- ((2- hydroxy- 3- (4- hydroxy- 3- ((methylsulfonyl)amino)phenoxy)propyl)amino)cyclohexyl)benzoate

3/2010SAR150640, a selective beta3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Goirand Research Topics

Disease

1Pathologic Processes
03/2020
1Cardiovascular Diseases (Cardiovascular Disease)
02/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2011
1Chorioamnionitis
03/2010
1Inflammation (Inflammations)
03/2010
1Pre-Eclampsia (Preeclampsia)
01/2006

Drug/Important Bio-Agent (IBA)

1CytokinesIBA
03/2020
1FructoseIBA
02/2011
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
02/2011
1Metalloproteases (Metalloproteinases)IBA
03/2010
1ethyl 4- (4- ((2- hydroxy- 3- (4- hydroxy- 3- ((methylsulfonyl)amino)phenoxy)propyl)amino)cyclohexyl)benzoateIBA
03/2010
1CollagenIBA
03/2010
1LipopolysaccharidesIBA
03/2010
1Matrix Metalloproteinases (MMPs)IBA
03/2010
1Pharmaceutical PreparationsIBA
01/2006
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2006